51786-11-9

Basic information

• Product Name: Benzonitrile, 2-chloro-3-hydroxy-
• Synonyms: Benzonitrile, 2-chloro-3-hydroxy-;2 - chloro - 3 - cyanophenol
• CAS NO: 51786-11-9
• Molecular Formula: C₇H₄ClNO
• Molecular Weight: 153.57
• Mol File: 51786-11-9.mol

Chemical Properties

• Boiling Point: 273.7±25.0 °C(Predicted)
• Appearance: /
• Density: 1.41±0.1 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 7.11±0.10(Predicted)
• CAS DataBase Reference: Benzonitrile, 2-chloro-3-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 2-chloro-3-hydroxy-(51786-11-9)
• EPA Substance Registry System: Benzonitrile, 2-chloro-3-hydroxy-(51786-11-9)

Safety Data

• Hazardous Substances Data: 51786-11-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Benzonitrile, 2-chloro-3-hydroxyis used as an intermediate in the synthesis of various pharmaceuticals for its potential therapeutic applications. Its anti-cancer properties make it a valuable component in the development of new drugs targeting cancer treatment.
Used in Agrochemical Industry:
Benzonitrile, 2-chloro-3-hydroxyalso serves as an intermediate in the production of agrochemicals, contributing to the development of pesticides and other agricultural chemicals that enhance crop protection and yield.
Used in Dye Production:
Benzonitrile, 2-chloro-3-hydroxyis utilized in the manufacturing process of dyes, where its chemical properties contribute to the creation of a diverse range of colorants for various industries.
Used in Organic Compounds Synthesis:
As a versatile chemical intermediate, Benzonitrile, 2-chloro-3-hydroxyis employed in the synthesis of other organic compounds, expanding its applications across different sectors in the chemical industry.
It is crucial to handle Benzonitrile, 2-chloro-3-hydroxywith care, considering its potential harmful effects on human health and the environment, and to adhere to proper safety and management protocols during its use in various applications.

Upstream product

• 211172-52-0 2-amino-3-hydroxybenzonitrile 
• 853331-52-9 2-chloro-3-methoxybenzonitrile 
• 56962-10-8 2-chloro-3-hydroxybenzaldehyde 
• 129298-23-3 3-hydroxy-2-nitrobenzonitrile 
• 873-62-1 m-cyanophenol 

Downstream Products

• 1227416-17-2 C₁₉H₁₂ClN₅O₂ 
• 1338327-04-0 2-chloro-3-cyanophenyl trifluoromethanesulfonate 

Relevant articles and documents

4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS

DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.

INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)

The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein ("FABP") inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the present invention is shown below: (I)

Substituted triazole derivatives as oxytocin antagonists

The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.

Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine Receptor

N,N′-Diarylureas were prepared, and the structure-activity relationship relative to the CXCR2 receptor was examined. This led to the identification of a potent and highly selective CXCR2 antagonist, which in addition was shown to be functionally active bo